Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
about
Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liverChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsFunctional characterization of a human receptor for neuropeptide FF and related peptidesCharacterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.Control of feeding behavior in C. elegans by human G protein-coupled receptors permits screening for agonist-expressing bacteria.Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophagesThe C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.A peptide inhibitor of cytomegalovirus infection from human hemofiltrateChemokine receptors: emerging opportunities for new anti-HIV therapies.A rapid and efficient way to obtain modified chemokines for functional and biophysical studiesQuantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Discovery of modulators of HIV-1 infection from the human peptidome.Pseudogenization of CCL14 in the Ochotonidae (pika) family.Control of HIV-1 infection by soluble factors of the immune response.PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4.Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cellsProteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.The clinical impact of ICOS signal in colorectal cancer patientsInternational Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in functionIn vivo regulation of chemokine activity by post-translational modification.CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways.Mechanisms of Regulation of the Chemokine-Receptor Network.An overview of Ca2+ mobilization assays in GPCR drug discovery.Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16.Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4.Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism.Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1.Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes.Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity.The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins.
P2860
Q24649303-756B8617-E22B-4B9E-9CD7-3B218C14C3DFQ26830743-0482BE43-4EDA-4ADD-8FFA-28649B63B872Q28363833-D9325859-3494-49FE-812E-C43D7788CF43Q31032679-53720C9E-E29A-4C8C-95E0-2A104438EA66Q33371683-8A9C0A5F-D73C-4824-883F-ABFAD02E94F8Q33602959-A2EC3227-88A7-4558-95BE-7FB03BA54846Q34106131-9E3CF556-2ACB-4EF1-AE0B-AC80F2128FC7Q34287228-44463FCC-6025-47CE-A6B5-35D7A105B2B7Q34821852-58B3707C-741B-4425-BBA0-3C93E7290E4CQ35050395-C0B9C350-2302-4191-BCB0-0262040C538DQ35078604-E514EC3E-3E1A-4493-9F1F-9F1DAD4DEB04Q35166976-34C2BFB4-DB05-4519-804B-F3AD6312B510Q35222585-A13BD2FA-8191-467C-B050-8647E03AF804Q35589167-DF739797-E310-4CFC-9DE6-5BC3A5C2CE4DQ35752416-E8A6DCB1-E9C7-4849-939D-A895D798CAD5Q35843496-A063F5F6-C93A-4D97-B7C4-BFBA20ED07F2Q35953364-D172A52E-B81B-4135-83B2-26081C32DA37Q36414426-415829D4-079E-4B3D-91DF-1DF9E5756985Q36845884-329E2CA1-608E-4511-9FFD-4906BF0EB34BQ36904560-D7569DA9-4D80-476B-B790-71947B2B9F99Q37012600-7697DA3B-C97F-4769-8A55-B0D208BE119EQ37432097-56A9E92D-4ABE-48C7-A578-4E1780618086Q37827607-BD52FEFA-52AA-465E-AE7F-2C6CF3C0CFA9Q38102877-BA37B9CA-244C-459A-A341-6BA29ED63C3EQ38690194-6F0FB948-D57D-435D-A699-DEC7C94E2769Q38911701-279DB677-58C6-4A41-8FA2-CBF5151E23B5Q39126530-A1541779-4F3F-458D-84A8-31B3D38689E2Q39170888-1B5EE89F-83C2-4502-9801-920184216D73Q39432022-8AF7B7A7-D7EE-4702-9C4F-F391EF3CCED0Q39546246-6D9391EB-A055-4DF7-974B-2B475A87D595Q39753053-2F5ED86A-D170-43AA-9135-5DC867D9427EQ39874881-1F301BFD-1B4A-4093-B5B5-0343886EF570Q40365547-642EA40A-A015-4D3D-B06B-0F2C9B3E2B74Q40385320-EEEB621C-153A-4EE9-8F69-95E8C2EEAB4BQ40536297-2D6EC5AB-193F-4ECB-92D5-AA95A2F782DCQ40790187-E2E80686-3479-4066-9871-B0487A17AB81Q41863417-92462024-40F2-411B-B1E1-135BB5229689Q42456034-6171CF7A-A011-4E73-960A-7FA1E7F1098DQ44238580-DCE13727-1B4A-4364-925F-290179345A40Q52372011-99B67979-A031-4867-8D77-96D3A601B8B2
P2860
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Natural proteolytic processing ...... onist with anti-HIV properties
@ast
Natural proteolytic processing ...... onist with anti-HIV properties
@en
Natural proteolytic processing ...... onist with anti-HIV properties
@nl
type
label
Natural proteolytic processing ...... onist with anti-HIV properties
@ast
Natural proteolytic processing ...... onist with anti-HIV properties
@en
Natural proteolytic processing ...... onist with anti-HIV properties
@nl
prefLabel
Natural proteolytic processing ...... onist with anti-HIV properties
@ast
Natural proteolytic processing ...... onist with anti-HIV properties
@en
Natural proteolytic processing ...... onist with anti-HIV properties
@nl
P2093
P2860
P356
P1476
Natural proteolytic processing ...... onist with anti-HIV properties
@en
P2093
F Kirchhoff
K Adermann
L Ständker
U Forssmann
W G Forssmann
P2860
P304
P356
10.1084/JEM.192.10.1501
P407
P577
2000-11-01T00:00:00Z